Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 5Phase 1 2Phase NA 1Phase 2/3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 5Sarcoma 2Head & Neck 2Gynecologic 2Genitourinary 2Thoracic 1Gastrointestinal 1Endocrine 1

Conditions

Kidney Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Congresses as Topic × Genitourinary × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

NCT00671411 2015-12-28

Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
42 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡